MARKET

VKTXW

VIKING THERAPEUT
VKTXW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-8.4559
-
1.378
-
Viking Therapeutics announces annual shareholder meeting webcast and proxy materials availability
Reuters · 3d ago
BUZZ-Eli Lilly rises after US FDA approves weight-loss pill
Reuters · 3d ago
Viking Therapeutics completes enrollment in Phase 3 VANQUISH-2 trial of VK2735; 78-week study targets about 1,000 adults with obesity and type 2 diabetes
Reuters · 03/26 11:05
VIKING THERAPEUTICS INC - COMPANY EXPECTS TO REPORT PHASE 1 STUDY RESULTS IN Q3 2026
Reuters · 03/26 11:05
Viking Therapeutics publishes corporate presentation on VK2735 obesity trials and VK2809 MASH program
Reuters · 03/13 22:30
Viking Therapeutics to Join Leerink Global Healthcare Conference 2026 Fireside Chat in Miami
Reuters · 03/05 21:03
BUZZ-U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National
Reuters · 02/12 18:36
BUZZ-U.S. STOCKS ON THE MOVE-Iron Mountain, BridgeBio, Old Dominion, 
Reuters · 02/12 15:36
More

Webull offers VIKING THERAPEUT stock information, including NASDAQ: VKTXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VKTXW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VKTXW stock methods without spending real money on the virtual paper trading platform.